| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.099 | 0.003 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.003 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.097 | 0.003 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.096 | 0.004 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.093 | 0.004 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | -0.095 | 0.005 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | -0.094 | 0.005 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.11 | 0.005 |